+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Pessary Market Size, Share & Trends Analysis Report by Type (Gellhorn, Ring, Donut), End-use (Hospitals, Ambulatory Surgical Centers, Clinics), Region, and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 120 Pages
  • December 2023
  • Region: Global
  • Grand View Research
  • ID: 5397835
The global pessary market size is expected to reach USD 547.2 million by 2028. The market is expected to expand at a CAGR of 9.2% from 2021 to 2028. An increase in the demand for pessaries has been witnessed in recent years as compared to the surgeries performed for pelvic organ prolapse. Easy and convenient application has largely favored the growing usage of pessaries among patients.

According to the U.S. Census Bureau, the number of women aged 65 years and above in America would double by 2030 to reach over 40 million. Vaginal pessaries have a high success rate and minimal complication rate for the treatment of both incontinence and prolapse. When successfully fitted, they are associated with high patient satisfaction.

Sedentary lifestyles and lifestyle-associated diseases are also expected to contribute to market growth. The increasing prevalence of diseases such as urinary inconsistency, pelvic organ prolapse and the rising number of geriatric population is fueling the demand for vaginal pessaries.

The market for vaginal pessary is competitive. The most notable participants in the market are CooperSurgical, Biotique America, and MedGyn. Key players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, CooperSurgical, based in the United States, invented the Milex Pessary Fitting Kit. The kit is designed for physicians and doctors who can use it to determine the exact size of the patient and prescribe the pessary accordingly. The introduction of these detailed analyses marks a significant shift in focus in the field of female healthcare around the world, which is propelling the market forward.

Pessary Market Report Highlights

  • In terms of type, the ring pessary segment dominated the market in 2022, since the device is easy to insert and remove
  • The hospitals segment held the largest revenue share in 2022, as they are the primary point of care for treatment, furthermore, hospitals are known to offer superior care to their patients, and treatment at these centers are generally reimbursed, which drives adoption
  • The clinic segment is predicted to witness the fastest growth rate over the forecast timeframe due to the increasing number of patient visits and advanced infrastructure in clinics
  • North America dominated the market in 2022 due to the increasing R&D spending, rising demand for medication development, strong governmental efforts, and current projects
  • Asia-Pacific is expected to register the fastest growth rate owing to numerous untapped growth opportunities in diagnostics and ever-increasing prevalence of pelvic organ prolapse.


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. End use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Pessary Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Pessary Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Pessary Market: Type Estimates & Trend Analysis
4.1. Pessary Market: Key Takeaways
4.2. Pessary Market: Type Movement & Market Share Analysis, 2022 & 2030
4.3. Gellhorn
4.3.1. Gellhorn market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Ring
4.4.1. Ring market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Donut
4.5.1. Donut market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Others
4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Pessary Market: End-use Estimates & Trend Analysis
5.1. Pessary Market: Key Takeaways
5.2. Pessary Market: End-use Movement & Market Share Analysis, 2022 & 2030
5.3. Hospitals
5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Clinics
5.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Ambulatory Surgical Centers
5.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Pessary Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Pessary Market by Region: Key Marketplace Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.5. Asia-Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. CooperSurgical Inc.
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Bliss GVS Pharma
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. MedGyn
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Panpac Medical Corporation
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Bioteque America
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Personal Medical Corporation
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Dr. Arabin GmbH & Co. KG
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Integra LifeSciences
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Wallach Surgical Devices
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America pessary market, by type, 2018-2030 (USD Million)
Table 3 North America pessary market, by end use, 2018-2030 (USD Million)
Table 4 North America pessary market, by region, 2018-2030 (USD Million)
Table 5 U.S. pessary market, by type, 2018-2030 (USD Million)
Table 6 U.S. pessary market, by end use, 2018-2030 (USD Million)
Table 7 Canada pessary market, by type, 2018-2030 (USD Million)
Table 8 Canada pessary market, by end use, 2018-2030 (USD Million)
Table 9 Europe pessary market, by type, 2018-2030 (USD Million)
Table 10 Europe pessary market, by end use, 2018-2030 (USD Million)
Table 11 Europe pessary market, by region, 2018-2030 (USD Million)
Table 12 Germany pessary market, by type, 2018-2030 (USD Million)
Table 13 Germany pessary market, by end use, 2018-2030 (USD Million)
Table 14 UK pessary market, by type, 2018-2030 (USD Million)
Table 15 UK pessary market, by end use, 2018-2030 (USD Million)
Table 16 France pessary market, by type, 2018-2030 (USD Million)
Table 17 France pessary market, by end use, 2018-2030 (USD Million)
Table 18 Italy pessary market, by type, 2018-2030 (USD Million)
Table 19 Italy pessary market, by end use, 2018-2030 (USD Million)
Table 20 Spain pessary market, by type, 2018-2030 (USD Million)
Table 21 Spain pessary market, by end use, 2018-2030 (USD Million)
Table 22 Sweden pessary market, by type, 2018-2030 (USD Million)
Table 23 Sweden pessary market, by end use, 2018-2030 (USD Million)
Table 24 Norway pessary market, by type, 2018-2030 (USD Million)
Table 25 Norway pessary market, by end use, 2018-2030 (USD Million)
Table 26 Denmark pessary market, by type, 2018-2030 (USD Million)
Table 27 Denmark pessary market, by end use, 2018-2030 (USD Million)
Table 28 Asia-Pacific pessary market, by type, 2018-2030 (USD Million)
Table 29 Asia-Pacific pessary market, by end use, 2018-2030 (USD Million)
Table 30 Asia-Pacific pessary market, by region, 2018-2030 (USD Million)
Table 31 China pessary market, by type, 2018-2030 (USD Million)
Table 32 China pessary market, by end use, 2018-2030 (USD Million)
Table 33 Japan pessary market, by type, 2018-2030 (USD Million)
Table 34 Japan pessary market, by end use, 2018-2030 (USD Million)
Table 35 India pessary market, by type, 2018-2030 (USD Million)
Table 36 India pessary market, by end use, 2018-2030 (USD Million)
Table 37 Australia pessary market, by type, 2018-2030 (USD Million)
Table 38 Australia pessary market, by end use, 2018-2030 (USD Million)
Table 39 Thailand pessary market, by type, 2018-2030 (USD Million)
Table 40 Thailand pessary market, by end use, 2018-2030 (USD Million)
Table 41 South Korea pessary market, by type, 2018-2030 (USD Million)
Table 42 South Korea pessary market, by end use, 2018-2030 (USD Million)
Table 43 Latin America pessary market, by type, 2018-2030 (USD Million)
Table 44 Latin America pessary market, by end use, 2018-2030 (USD Million)
Table 45 Latin America pessary market, by region, 2018-2030 (USD Million)
Table 46 Brazil pessary market, by type, 2018-2030 (USD Million)
Table 47 Brazil pessary market, by end use, 2018-2030 (USD Million)
Table 48 Mexico pessary market, by type, 2018-2030 (USD Million)
Table 49 Mexico pessary market, by end use, 2018-2030 (USD Million)
Table 50 Argentina pessary market, by type, 2018-2030 (USD Million)
Table 51 Argentina pessary market, by end use, 2018-2030 (USD Million)
Table 52 Middle East and Africa pessary market, by type, 2018-2030 (USD Million)
Table 53 Middle East and Africa pessary market, by end use, 2018-2030 (USD Million)
Table 54 Middle East and Africa pessary market, by region, 2018-2030 (USD Million)
Table 55 South Africa pessary market, by type, 2018-2030 (USD Million)
Table 56 South Africa pessary market, by end use, 2018-2030 (USD Million)
Table 57 Saudi Arabia pessary market, by type, 2018-2030 (USD Million)
Table 58 Saudi Arabia pessary market, by end use, 2018-2030 (USD Million)
Table 59 UAE pessary market, by type, 2018-2030 (USD Million)
Table 60 UAE pessary market, by end use, 2018-2030 (USD Million)
Table 61 Kuwait pessary market, by type, 2018-2030 (USD Million)
Table 62 Kuwait pessary market, by end use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Pessary: market outlook
Figure 9 Pessary market: competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Pessary market driver impact
Figure 15 Pessary market restraint impact
Figure 16 Pessary market strategic initiatives analysis
Figure 17 Pessary market: Type movement analysis
Figure 18 Pessary market: Type outlook and key takeaways
Figure 19 Gellhorn market estimates and forecasts, 2018-2030 (USD Million)
Figure 20 Ring market estimates and forecasts, 2018-2030 (USD Million)
Figure 21 Donut market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 23 Pessary market: End-use movement analysis
Figure 24 Pessary market: End-use outlook and key takeaways
Figure 25 Hospitals market estimates and forecasts, 2018-2030 (USD Million)
Figure 26 Clinics market estimates and forecasts, 2018-2030 (USD Million)
Figure 27 Ambulatory surgical centers market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Global pessary market: Regional movement analysis
Figure 29 Global pessary market: Regional outlook and key takeaways
Figure 30 North America market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 Canada market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Europe market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 UK market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Germany market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 France market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 Italy market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Spain market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Norway market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Asia-Pacific market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 China market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Japan market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 India market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Australia market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 Middle East and Africa market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 UAE market estimates and forecasts, 2018-2030 (USD Million)
Figure 57 Kuwait market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • CooperSurgical Inc.
  • Bliss GVS Pharma
  • MedGyn
  • Panpac Medical Corporation
  • Bioteque America
  • Personal Medical Corporation
  • Dr. Arabin GmbH & Co. KG
  • Integra Lifesciences
  • Wallach Surgical Devices

Methodology

Loading
LOADING...